Related Experiment Videos
Insulin-like growth factor binding protein-2 modulates podocyte mitogenesis.
Darren J Bridgewater1, Douglas G Matsell
1Department of Anatomy and Cell Biology, University of Western Ontario, 1151 Richmond Street, N6A 5B8, London, Ontario, Canada.
Pediatric Nephrology (Berlin, Germany)
|September 5, 2003
Summary
Insulin-like growth factor-II (IGF-II) stimulates fetal podocyte growth but also increases IGF binding protein 2 (IGFBP-2) production. This IGFBP-2 appears to inhibit IGF-II
Area of Science:
- Nephrology
- Developmental Biology
- Endocrinology
Background:
- Podocyte maturation is crucial for kidney development and function.
- Insulin-like growth factors (IGFs) are implicated in cellular growth and differentiation.
- Understanding IGF signaling in fetal podocytes is key to comprehending kidney development.
Purpose of the Study:
- To investigate the role of IGFs in human fetal podocyte maturation.
- To characterize the interaction between IGF-II and IGF binding protein 2 (IGFBP-2) in podocytes.
Main Methods:
- Isolation and characterization of fetal podocytes from human kidneys (8-18 weeks gestation).
- Immunoreactivity assays for podocyte markers (synaptopodin, WT-1, CR1, actin, vimentin).
- Stimulation with IGF-II and assessment of mitogenesis, IGFBP-2 production, and mRNA levels.
Main Results:
- Cultured fetal podocytes expressed specific markers and responded to IGF-II.
- IGF-II stimulation increased podocyte mitogenesis, which was blocked by IGFBP-2.
- IGF-II enhanced endogenous IGFBP-2 production in a dose- and time-dependent manner.
Conclusions:
- IGF-II promotes fetal podocyte mitogenesis.
- IGF-II also upregulates IGFBP-2, which may act in an autocrine fashion to regulate podocyte maturation, differentiation, and survival.
- This suggests a feedback mechanism controlling podocyte development.